The Commission first carried out unannounced inspections at the premises of several Teva subsidiaries in October 2019 and in March 2021 initiated an investigation over its practices relating to Copaxone, which is widely used to treat multiple sclerosis.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/IeLPBHS
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» European Commission suspects pharma group Teva broke antitrust rules
https://ift.tt/1iITkuS
No comments:
Post a Comment